Search

Author/Creator Qu, Hongjing

1. BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression. Issue 9 (12th September 2022)

Authors:
Mandel, Ilana; Haves Ziv, Dana; Goldshtein, Ilana; Peretz, Tsuri; Alishekevitz, Dror; Fridman Dror, Anna; Hakim, Motti; Hashmueli, Sharon; Friedman, Itay; Sapir, Yair; Greco, Rita; Qu, Hongjing; Nestle, Frank; Wiederschain, Dmitri; Pao, Lily; Sharma, Sharad; Ben Moshe, Tehila
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 9(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade. (1st January 2020)

Authors:
Greco, Rita; Qu, Hongjing; Qu, Hui; Theilhaber, Joachim; Shapiro, Gary; Gregory, Richard; Winter, Christopher; Malkova, Natalia; Sun, Frank; Jaworski, Julie; Best, Annie; Pao, Lily; Hebert, Andrew; Levit, Mikhail; Protopopov, Alexei; Pollard, Jack; Bahjat, Keith; Wiederschain, Dmitri; Sharma, Sharad
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search